BioMidwest
Filter News
Found 61,172 articles
-
PolyActiva Completes Recruitment in Key Phase I Glaucoma Implant Safety Study. Six-month Treatment Period Demonstrated.
7/23/2019
PolyActiva Pty Ltd, a clinical-stage biotechnology company and leader in ocular drug delivery, has completed patient enrolment for its Phase I clinical trial to study safety and tolerability of its biodegradable, slow-release ocular implant for the treatment of glaucoma.
-
NorthStar Medical Radioisotopes Awarded $30 Million Cooperative Agreement by U.S. Department of Energy’s National Nuclear Security Administration to Expand Domestic Molybdenum-99 (Mo-99) Production
7/23/2019
NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that it has been awarded $15 million in a cooperative agreement with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of an industry outreach initiative to establish reliable domestic molybdenum-99 (Mo-99) production without the use of highly enriched uranium.
-
DBA adds second top-ranked health system, Michigan Medicine, to client roster
7/23/2019
Academic medical centers have been a long-standing focus area for independent ad agency Daniel Brian Advertising; the recent addition of the Michigan Medicine means DBA now represents two of the top-ranked U.S. hospitals.
-
BioGenerator Wins $750,000 Federal Grant to Build New St. Louis Agtech Companies
7/23/2019
Grant expands BioGenerator Labs and Commercialization Resources
-
Kalderos Announces Strategic Hires
7/23/2019
The leader in drug discount management software adds a variety of talent to advance mission of adding transparency to the business of health care.
-
BlueWillow Biologics Awarded Patent for Intranasal Genital Herpes Vaccine
7/23/2019
BlueWillow Biologics® today announced the issuance of U.S. patent number 10,206,996 to BlueWillow for the development of an intranasal NanoVax® herpes simplex virus (HSV) vaccine.
-
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay
7/23/2019
Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne for use in its proprietary Simple Plex™ immunoassays on Ella.
-
Surmodics to Webcast Third Quarter Fiscal 2019 Earnings Conference Call on July 31
7/23/2019
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2019 conference call on Wednesday, July 31, at 4 p.m. CT (5 p.m. ET).
-
Cypris Medical Announces Commercial Launch of Xact Device
7/23/2019
Only Minimally Invasive Option for Effective and Lasting Treatment of Gravitational Descent in the Face and Neck
-
Digi International Delivers FirstNet Ready Digi WR54 for Public Safety
7/23/2019
Digi International®, (NASDAQ: DGII), (www.digi.com), a leading global provider of Internet of Things (IoT) connectivity products and services, is pleased to announce that its Digi® WR54, an extremely reliable, secure, high-performance wireless router for complex mobile and industrial environments, is now tested and approved for use on the FirstNet communications platform.
-
Louisiana Implements Nurse Licensure Compact (NLC)
7/23/2019
On July 1, 2019, Louisiana joined 30 other states in implementing the NLC, which allows for registered nurses and licensed practical/vocational nurses to have one multistate license, with the ability to practice in person or via telehealth, in both their home state and other NLC states.
-
Medical Centers Specialize To Treat Patients With Complex Lung Disease
7/23/2019
The Pulmonary Fibrosis Foundation (PFF) today announced that eight new sites have joined its Care Center Network (CCN) to help serve the more than 200,000 Americans living with pulmonary fibrosis (PF), a devastating disease which causes progressive scarring in the lungs
-
Neogen reports fiscal 2019 results
7/23/2019
Neogen Corporation (NASDAQ: NEOG) announced today that revenues for the fourth quarter of its 2019 fiscal year, which ended May 31, were $109,762,000, compared to $108,120,000 the prior year quarter.
-
Key Surgical Signs Agreement To Acquire Insitumed
7/23/2019
Global Provider Continues to Expand Product Portfolio
-
Centene Corporation Reports 2019 Second Quarter Results And Increases 2019 Guidance
7/23/2019
2019 Second Quarter Diluted EPS of $1.18; Adjusted Diluted EPS of $1.34
-
For John Cumbers, chief executive officer of SynBioBeta, turning rural America into a biotech hotbed may be an answer to kick start the local economies and advance new products that could benefit the nation and world.
-
Clinical Catch-up for July 15-19
7/22/2019
Here's a look at the top clinical trial news from last week, with updates from Neon, GSK, Biohaven, and more. -
Myxredlin is intended for use only in acute care settings under medical supervision.
-
SHINE Files Application With Federal Regulators to Produce Medical Isotopes in Short Supply
7/22/2019
SHINE Medical Technologies LLC today announced that the company has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes, including molybdenum-99 (Mo-99), iodine-131 and xenon-133, at its production facility in Janesville, WI. SHINE broke ground on the facility in May of this year.
-
Ocuphire Pharma Raises Over $5 Million to Complete Multiple Late Phase 2 Clinical Trials
7/22/2019
Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company focused on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders, announced today that it has closed on over $5 million of financing.